Pneumocystis Infection in Pregnant Women: A Scoping Review

Irene Calderón-Baturone1, Rocío Salsoso2, Elena Charpentier2,3

  • 1Programa de Doctorado en Ciencias de la Salud, Universidad de Sevilla, 41009 Seville, Spain.

Insights

Pneumocystis jirovecii pneumonia is a risk for pregnant women, especially those with HIV or hematologic malignancies. More research is needed on its transmission and effects on newborns.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Obstetrics & Gynecology

Background:

  • Pneumocystis jirovecii causes severe pneumonia in immunocompromised individuals.
  • Pregnancy involves immune modulation, potentially increasing risks for maternal colonization/infection and vertical transmission.
  • Understanding Pneumocystis in pregnancy is crucial for maternal and neonatal health.

Purpose of the Study:

  • To map existing evidence on Pneumocystis colonization and infection during pregnancy.
  • To identify knowledge gaps, prevalence, risk factors, and neonatal outcomes.
  • To inform clinical practice and future research directions.

Main Methods:

  • A scoping review following PRISMA-ScR guidelines.
  • Systematic literature search across three databases.
  • Inclusion of 26 studies (19 pneumonia, 7 colonization).

Main Results:

  • Most Pneumocystis pneumonia cases in pregnant women were linked to pre-antiretroviral therapy HIV; recent cases involved hematologic malignancies.
  • Pneumocystis colonization rates varied significantly (5.4-46.5%).
  • Evidence suggests vertical transmission, but neonatal impact requires further investigation.

Conclusions:

  • HIV screening in pregnant women is recommended.
  • Pneumocystis should be considered in the differential diagnosis of pneumonia in pregnant women.
  • Increased awareness and research are vital for improving maternal and neonatal outcomes.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...